Both in Pharmaceuticals
USANA Health Sciences vs BioAge Labs
Over the past year USNA returned −28.1% and BIOA returned −24.7%; their daily moves had a correlation of 0.09.
USNA −28.1% BIOA −24.7%Growth of $1, one year, split-adjusted
| Metric | USNA | BIOA |
|---|---|---|
| Price | $14.22 | $5.80 |
| Market cap | $262.7M | $266.2M |
| Today | +1.07% | +6.03% |
| 1 month | −3.3% | −18.8% |
| 6 months | −24.0% | −65.6% |
| Year to date | −27.6% | −56.2% |
| 1 year | −29.3% | −24.0% |
| Revenue growth (YoY) | −5.3% | +1.6% |
| Gross margin | 78.3% | 100.0% |
| Net margin | −9.6% | −1064.7% |
| P/E (TTM) | — | — |
| Price / sales | 0.3× | 25.7× |
| Net cash | $168.6M | $318.7M |
| Dividend yield | — | — |
| Volatility (60d) | 92.8% | 66.9% |
| Short % of float | 7.2% | 12.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).